Top compounds associated with response to LGALS9

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.15	0.0002
mRNA	ATRA	CTRPv2	pan-cancer	AAC	0.14	0.0002
mRNA	selumetinib:vorinostat (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.15	0.0002
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	0.0002
mRNA	BX-912	GDSC1000	pan-cancer	AAC	0.12	0.0002
mRNA	chlorambucil	CTRPv2	pan-cancer	AAC	0.13	0.0002
mRNA	selumetinib:decitabine (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.13	0.0003
mRNA	MGCD-265	CTRPv2	pan-cancer	AAC	0.14	0.0003
mRNA	Sorafenib	GDSC1000	pan-cancer	AAC	0.21	0.0003
mRNA	ruxolitinib	CTRPv2	pan-cancer	AAC	0.13	0.0004

Download CSV